BSE: SANOFI - Sanofi India Limited

Altı ay boyunca karlılık: -12.85%
Temettü getirisi: +1.51%

Promosyon programı Sanofi India Limited

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Sanofi India Limited

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors.

daha fazla ayrıntı
It also exports its products to approximately 35 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

ISIN INE058A01010
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 1.71
Дивиденд ао 68.21
Сайт https://www.sanofiindialtd.com
Цена ао 5592.35
Günlük fiyat değişimi: -0.4488% (5592.35)
Haftalık fiyat değişimi: -6.84% (5976.1)
Aylık fiyat değişimi: -10.28% (6205.25)
3 ayda fiyat değişimi: -18.95% (6869)
Altı ayda fiyat değişimi: -12.85% (6388.45)
Yıllık fiyat değişimi: -32.38% (8233.25)
3 yılda fiyat değişimi: -25.95% (7518.15)
5 yılda fiyat değişimi: -20.95% (7042.75)
10 yılda fiyat değişimi: 0% (5567.25)
Yılbaşından bu yana fiyat değişimi: -10.76% (6238.8)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 6.55 1
P/BV 18.17 1
P/E 30.59 5
EV/EBITDA 17.69 6
Toplam: 4.63

Yeterlik

İsim Anlam Seviye
ROA, % 35.16 9
ROE, % 59.39 10
Toplam: 5.83

Temettüler

İsim Anlam Seviye
Div yield, % 1.51 3.78
DSI 0.8571 8.57
Toplam: 4.94

Görev

İsim Anlam Seviye
Debt/EBITDA 0.026 10
Toplam: 10

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % -8.24 0
karlılık Ebitda, % 20.55 4
karlılık EPS, % 50.5 7
Toplam: 3.4
Daha fazla ayrıntı

ETF Paylaşmak, % Yıllık karlılık, % Temettüler, %
iShares MSCI India Small-Cap ETF 0.16695 0.4625 0.96163
SPDR S&P Emerging Markets Small Cap ETF 0.07114 5.46 3.03583
iShares MSCI Emerging Markets Small-Cap ETF 0.04483 7.67 2.7853
Avantis Emerging Markets Value ETF 0.03441 14.12 4.22231
Avantis Responsible Emerging Markets Equity ETF 0.02777 17.6 3.1719
Vanguard FTSE All-World ex-US Small-Cap ETF 0.02 9.39 3.09932
Avantis Emerging Markets Equity ETF 0.01484 8.77 3.60513
Dimensional Emerging Markets Core Equity 2 ETF 0.0079 15.96 3.34087
Dimensional World ex U.S. Core Equity 2 ETF 0.00469 13.06 3.62488
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.00447 12.46 3.59676

Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Rodolfo Hrosz MD & Director 17.85M 1967 (58 yıllar)
Mr. M. K. Narayanaswamy B.Com.,A.I.C.W.A. Senior Director of Accounting & Taxation N/A 1955 (70 yıllar)
Mr. Sanjay V. Chavan Head of Country Procurement - India N/A 1962 (63 yıl)
Ms. Surabhi Kaur People & Culture Director N/A
Ms. Renee Amonkar Additional Whole Time Director N/A
Mr. Rachid Ayari CFO & Whole Time Director N/A
Ms. Flovie Martins Head of Corporate Communications & Corporate Social Responsibility
Nakul Verma Senior Director of Public Affairs
Yasmin Shenoy Senior Director of Regulatory Affairs
Mr. N. Suresh Babu Sales & Customer Engagement Head - Diabetes and Senior Director of Diabetes

Adres: India, Mumbai, Sanofi House - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.sanofiindialtd.com